trimethoprim--sulfamethoxazole-drug-combination and Small-Cell-Lung-Carcinoma

trimethoprim--sulfamethoxazole-drug-combination has been researched along with Small-Cell-Lung-Carcinoma* in 1 studies

Other Studies

1 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Small-Cell-Lung-Carcinoma

ArticleYear
First report of Tsukamurella endocarditis in an immunocompromised patient receiving chemotherapy.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:10

    Tsukamurella spp. are gram-positive rods that can be isolated from the environment in soil and moist areas. In rare instances, they are known to cause infections in immunocompromised hosts. We present the first reported case of Tsukamurella endocarditis in an immunocompromised patient who was successfully treated with a 6-week course of imipenem and trimethoprim-sulfamethoxazole.

    Topics: Actinobacteria; Anti-Bacterial Agents; Antineoplastic Agents; Diagnosis, Differential; Endocarditis, Bacterial; Female; Humans; Imipenem; Immunocompromised Host; Lung Neoplasms; Middle Aged; Small Cell Lung Carcinoma; Trimethoprim, Sulfamethoxazole Drug Combination

2020